• Explore /
  • Poster
  • / A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.

A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.

Abstract Poster

Authors

null

Mototsugu Oya

Department of Urology, Keio University School of Medicine, Tokyo, Japan

Mototsugu Oya , Satoshi Tamada , Katsunori Tatsugami , Noboru Nakaigawa , Takahiro Osawa , Hiro-Omi Kanayama , Chihiro Kondoh , Naoto Sassa , Kazuo Nishimura , Masahiro Nozawa , Naoya Masumori , Yasuhide Miyoshi , Akiko Kimura , Shingo Kuroda , Robert J. Motzer , Toni K. Choueiri , Yoshihiko Tomita

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Other GU Kidney and Bladder Cancer

Clinical Trial Registration Number

NCT03339219, NCT01865747

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5089)

DOI

10.1200/JCO.2020.38.15_suppl.5089

Abstract #

5089

Poster Bd #

158

Abstract Disclosures

Similar Posters

First Author: Bernard J. Escudier

First Author: Thomas Powles

First Author: Andrew Johns

First Author: Michael D. Staehler